DE VIVO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 1.524
EU - Europa 1.061
AS - Asia 931
AF - Africa 82
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.638
Nazione #
US - Stati Uniti d'America 1.519
CN - Cina 297
SG - Singapore 278
GB - Regno Unito 269
SE - Svezia 175
VN - Vietnam 150
DE - Germania 140
IT - Italia 127
HK - Hong Kong 67
IN - India 59
UA - Ucraina 55
RU - Federazione Russa 46
FR - Francia 44
CH - Svizzera 38
IE - Irlanda 37
NL - Olanda 36
TG - Togo 35
BR - Brasile 30
BG - Bulgaria 22
FI - Finlandia 22
KR - Corea 22
JO - Giordania 21
EE - Estonia 20
ZA - Sudafrica 19
JP - Giappone 16
CI - Costa d'Avorio 15
BE - Belgio 13
IR - Iran 7
GR - Grecia 6
LB - Libano 6
ID - Indonesia 5
PL - Polonia 4
EC - Ecuador 3
MA - Marocco 3
MX - Messico 3
NG - Nigeria 3
RO - Romania 3
SC - Seychelles 3
CA - Canada 2
CO - Colombia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CM - Camerun 1
EG - Egitto 1
ES - Italia 1
GE - Georgia 1
HR - Croazia 1
MY - Malesia 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 3.638
Città #
Southend 235
Ashburn 190
Singapore 187
Fairfield 169
Chandler 139
Woodbridge 94
Ann Arbor 89
Houston 88
Seattle 79
Wilmington 66
Hong Kong 64
Hefei 59
Santa Clara 46
Princeton 44
Cambridge 42
Beijing 40
Dublin 37
Bern 36
Jacksonville 36
Lomé 35
Boardman 32
Dong Ket 32
Nanjing 25
Turin 23
Seoul 22
Amman 21
Padova 21
Sofia 21
Westminster 21
Helsinki 20
Milan 19
New York 19
Munich 17
Los Angeles 16
Berlin 15
Buffalo 15
Ho Chi Minh City 15
Tokyo 15
Abidjan 14
Bremen 13
Brussels 13
Changsha 13
Dallas 13
Washington 12
Bologna 11
Falkenstein 9
Saint Petersburg 9
San Diego 9
Jinan 8
Hanoi 7
Hebei 7
Shenyang 7
Florence 6
London 6
Nanchang 6
Redondo Beach 6
Zhengzhou 6
Bengaluru 5
Frankfurt am Main 5
Guangzhou 5
Jiaxing 5
Mülheim 5
Dearborn 4
Des Moines 4
Haikou 4
Ningbo 4
Phoenix 4
São Paulo 4
Taiyuan 4
Zanjan 4
Abeokuta 3
Bühl 3
Chennai 3
Denver 3
Hải Dương 3
Jakarta 3
Mahé 3
Norwalk 3
Paris 3
San Francisco 3
Verona 3
Warsaw 3
Wuhan 3
Amboise 2
Athens 2
Boston 2
Boydton 2
Cardito 2
Chengdu 2
Da Nang 2
Falls Church 2
Fuzhou 2
Handan 2
Hangzhou 2
Jaguaquara 2
Kuban 2
Kunming 2
Lang Son 2
Langfang 2
Lanzhou 2
Totale 2.449
Nome #
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia 254
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 238
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia 235
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia 221
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 200
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. 196
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience 190
BU/melphalan and auto-SCT in AML patients in first CR: a 'Gruppo Italiano Trapianto di Midollo Osseo (GITMO)' retrospective study. 169
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. 165
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma. 160
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML. 148
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy. 142
Intestinal microflora and digestive toxicity of irinotecan in mice. 139
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 136
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. 134
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 132
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 122
Resolution of a Pseudomonas aeruginosa outbreak in a hematology unit with the use of disposable sterile water filters. 114
INTERMITTENT IMATINIB (INTERIM) TREATMENT IN PH+-CML ELDERLY PATIENTS IN STABLE COMPLETE CYTOGENETIC RESPONSE 114
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 99
Differences among young adults, adults and elderly chronic myeloid leukemia patients 87
null 81
null 76
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study. 70
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia 43
Erratum: Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia (Blood (2013) 121:26 (5138-5144)) 35
Totale 3.700
Categoria #
all - tutte 9.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021205 0 0 0 0 0 16 3 16 24 25 20 101
2021/2022509 56 12 27 67 41 22 5 31 16 38 113 81
2022/2023621 66 103 38 70 36 46 17 29 94 14 57 51
2023/2024204 10 22 20 29 18 67 7 9 1 5 11 5
2024/2025499 8 51 39 38 82 40 40 14 3 42 26 116
2025/2026593 116 96 127 72 120 62 0 0 0 0 0 0
Totale 3.700